Edwards Lifesciences (EW) FCF Margin (QoQ) (2009 - 2026)
Edwards Lifesciences (EW) FCF Margin (QoQ) (2009 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn |
| 3 | Medtronic | 119.95 Bn | 110.73 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.85 Bn | 73.31 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.69 Bn | 48.44 Bn | 1.35 Bn |
| 6 | Dexcom | 34.55 Bn | 32.60 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.11 Bn | 32.00 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn |
| 9 | Steris | 23.22 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,488.00 |
| Mar 31, 2026 | -2,380.00 |
| Dec 31, 2025 | -1,072.00 |
| Sep 30, 2025 | 1,751.00 |
| Jun 30, 2025 | -16.00 |
| Mar 31, 2025 | 2,868.00 |
| Dec 31, 2024 | -3,494.00 |
| Sep 30, 2024 | 125.00 |
| Jun 30, 2024 | 2,983.00 |
| Mar 31, 2024 | -1,275.00 |
| Dec 31, 2023 | -2,483.00 |
| Sep 30, 2023 | 2,977.00 |
| Jun 30, 2023 | -2,180.00 |
| Mar 31, 2023 | -2,907.00 |
| Dec 31, 2022 | 3,080.00 |
| Sep 30, 2022 | -209.00 |
| Jun 30, 2022 | 459.00 |
| Mar 31, 2022 | -490.00 |
| Dec 31, 2021 | -1,462.00 |
| Sep 30, 2021 | 277.00 |